Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 580 participants.
Also called NCT06242145
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 580 participants
- Sponsor
- Registry
-
NCT06242145
-
- Other papers using this trial's data
- Cilostazole versus clopidogrel in acute large-vessel moderate and moderate-to-severe ischemic stroke: a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT06242145. Randomized; double masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2024-07-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Clopidogrel tablet
- Intervention (Drug)
- Cilostazol 100 MG
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06242145- Content hash
536fbc6a459885b71420f45dc015a1dfaaa88fafdaf116b71cce04ed323a72fa